SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001445305-12-001023
Filing Date
2012-04-16
Accepted
2012-04-16 16:20:55
Documents
6
Period of Report
2012-04-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FROM 8-K/A a8-kaenobiaacquisition.htm 8-K/A 23752
2 CONSENT OF PRICEWATERHOUSECOOPERS LLP alxn23consentofpricewaterh.htm EX-23 3176
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF ENOBIA alxn992enobiafinancialstat.htm EX-99.2 1381657
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION alxn993proformaexhibit.htm EX-99.3 213910
5 GRAPHIC newpwclogo2.jpg GRAPHIC 16803
6 GRAPHIC pwcsignature.jpg GRAPHIC 17129
  Complete submission text file 0001445305-12-001023.txt   1670632
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-27756 | Film No.: 12761257
SIC: 2834 Pharmaceutical Preparations